Hyperion Partners, LLC Cel Sci Corp Transaction History
Hyperion Partners, LLC
- $137 Billion
- Q1 2024
A detailed history of Hyperion Partners, LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Hyperion Partners, LLC holds 14,100 shares of CVM stock, worth $17,061. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,100
Previous 14,100
-0.0%
Holding current value
$17,061
Previous $38.4 Million
29.78%
% of portfolio
0.02%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding CVM
# of Institutions
83Shares Held
7.5MCall Options Held
61.8KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA2.19MShares$2.65 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE879KShares$1.06 Million12.54% of portfolio
-
Black Rock Inc. New York, NY763KShares$923,7660.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA669KShares$809,4760.0% of portfolio
-
Geode Capital Management, LLC Boston, MA464KShares$561,9340.0% of portfolio
About CEL SCI CORP
- Ticker CVM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,367,500
- Market Cap $52.5M
- Description
- CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...